Previous Article | Next Article 
Applied and Environmental Microbiology, January 2001, p. 473-474, Vol. 67, No. 1
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.1.473-474.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Pigment Production by Streptococcus
agalactiae in Quasi-Defined Media
Manuel
Rosa-Fraile,1,*
Antonio
Sampedro,1
Javier
Rodríguez-Granger,1
Maria
Luisa
García-Peña,1
Alfonso
Ruiz-Bravo,2 and
Ali
Haïdour3
Microbiology Service, Virgen de las Nieves
Hospital, 18014 Granada,1 and Department
of Microbiology,2 and Centro de
Instrumentación Cientifica,3 University of
Granada, 18071 Granada, Spain
Received 24 July 2000/Accepted 28 October 2000
 |
ABSTRACT |
A quasi-defined medium that supports the growth of
Streptococcus agalactiae as pigmented colonies has been
developed. The medium contains starch, a peptic digest of albumin,
amino acids, nucleosides, vitamins, and salts. The presence of free
cysteine, which could be replaced with other sulphur-containing
compounds and to a lesser degree by reducing agents, was required for
pigment formation.
 |
TEXT |
Streptococcus agalactiae
(Group B streptococci [GBS]) is a leading cause of infections in
newborns and adults (14). Production of an orange-red
pigment integrated in the cell wall (5) is a specific
characteristic of human hemolytic GBS and serves as the basis for use
of culture media to identify GBS from clinical samples (2,
9).
Media for GBS pigment detection are complex, since they must contain
starch (2, 5, 16), serum (2), a specific
peptone (proteose peptone no. 3; Becton Dickinson, Difco, Franklin
Lakes, N.J.) (2, 4, 16), and a folate pathway inhibitor
(8). The component that accounts for the serum
pigment-enhancing activity is amylase (10). The active
peptide from peptones necessary for pigment production is
Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe (11), and this peptide is
produced when albumin is hydrolyzed with pepsin.
Though some defined media for growth of streptococci have been
described previously (6, 18, 20), in the few published studies of the dynamics of pigment production, GBS have been grown in
complex media (15, 16, 17). The present study was designed to devise simpler media able to support growth and pigment production by GBS. This should aid improvement of media for GBS pigment detection and future investigation into the metabolic pathway that leads to
pigment production.
Three beta-hemolytic GBS strains were used to develop the new media.
Two of them were isolated from patients and identified by accepted
procedures (Gram stain, beta-hemolysis, detection of group B antigen,
and CAMP test) (13), and the other was S. agalactiae ATCC 12386. Experiments aimed at developing the new quasi-defined media were repeated at least three times. The ability of
these media to support GBS growth and GBS pigment production was also
tested using another 20 GBS strains isolated from clinical samples.
Plates of the media were inoculated with 10 µl of a suspension prepared by homogenizing a colony from a blood agar culture in 10 ml of
sterile 0.85% NaCl. Pigment was detected by inspection of the surfaces
of plates after 24 h at 36°C in anaerobiosis or under a
coverslide (12). Pigment intensity was graded from 0 (no
pigment) to 4+ (strong red, as with colonies of strain ATCC 12386 after
24 h of anaerobic incubation in Granada medium).
We assayed first an agar medium (CAM medium) derived from Granada
medium (9) in which proteose peptone no. 3, horse serum, colistin, crystal violet, and metronidazole were not present and the
only components not completely defined were casamino acids and albumin
digest. CAM medium contained, per liter, the following: 10 g of
purified agar (Oxoid, Basingstoke, United Kingdom); 10 g of peptic
digest of albumin prepared by hydrolyzing a 5% solution of bovine
albumin (fatty acid free) (Sigma Chemical Co., St. Louis, Mo.) with hog
pepsin (1:60,000; Sigma) (0.05 mg/mg of protein) at 50°C for 20 h, after adjusting the pH to 2.5 with HCl; 10 g of soluble starch
(1252; Merck, Darmstadt, Germany); 10 g of glucose; 5 g of
amino acids (casamino acids, vitamin assay; BD, Difco); 1 g of
sodium pyruvate; 6 mg of methotrexate sodium salt; nucleosides (100 mg
each of adenosine, cytidine, guanosine, thymidine, and uridine);
vitamins (5 mg each of biotin, calcium pantothenate, choline, folic
acid, inositol, p-aminobenzoic acid, thiamine, pyridoxal and
nicotinamide, and 2.5 mg of riboflavin); salts (MgSO4 [200
mg], Cl2K [100 mg], Cl2Mn [25 mg],
NH4
(SO4)2Fe6OH2 [25 mg], and Cl2Ca [10 mg]); and buffer (Na2H
PO4 [8.5 g] and morpholinopropanesulphonic acid
hemisodium salt [11 g]).
Several modifications of CAM medium were also tested (Table
1): (i) CAM medium supplemented with
cysteine at 50 µg/ml (CAM-Cy medium), (ii) CAM medium in which
casamino acids were replaced with a defined mixture containing all the
amino acids (including cysteine) present in Eagle's medium for cell
culture (1) at 50 µg/ml (AM-Cy medium), and (iii) AM-Cy
medium without cysteine (AM medium). In addition, some further culture
media, in which other sulphur-containing compounds (cystine at 50 µg/ml, glutathione reduced or oxidized at 250 µg/ml,
2-mercaptoethanol at 100 µg/ml, thioglycolic acid at 500 µg/ml, or
dithiothreitol at 500 µg/ml) or reducing compounds (sodium
metabisulfite at 200 µg/ml or ascorbic acid at 1,000 µg/ml) were
substituted for cysteine in CAM-Cy and AM-Cy media, were also assayed.
Media were prepared just before inoculation, sterilized in a boiling
water bath for 10 min, and cooled to 48°C before pouring. Glucose,
pyruvate, methotrexate, and all reducing compounds were added as
filter-sterilized solutions after cooling.
GBS grew in all these media as colonies of similar size to those grown
in blood agar (1 to 1.5 mm). In CAM and AM media (both without
cysteine), colonies were white, and in CAM-Cy and AM-Cy media, GBS
colonies were orange-red (pigment intensity, 2+, 3+) (Table 1). In the
media where cystine, glutathione, 2-mercaptoethanol, thioglycolic acid,
or dithiothreitol substituted for cysteine, GBS grew as orange-red
colonies (pigment intensity, 2+, 3+). When sodium metabisulfite or
ascorbic acid substituted for cysteine, GBS also grew as orange-red
colonies, but pigment production was weaker (1+, 2+). All three GBS
strains used to develop these media grew with the same characteristics
after three successive subcultures in the same medium. And all the
additional GBS strains tested grew as white colonies in CAM and AM
media and as pigmented colonies in CAM-Cy and AM-Cy media.
GBS has an absolute nutritional requirement for cystine, which
could be replaced with cysteine or glutathione but not with thioglycolate or dithiothreitol (6, 7, 18, 20). On the other hand, the effects of cysteine on stimulation of GBS growth from a
small inoculum (20) seem related to the redox potential reduction, because other reducing agents, such as thioglycolic and
ascorbic acids, can be substituted for cysteine. Regarding GBS pigment,
anaerobic incubation in CAM and AM media (both without cysteine) did
not lead to pigment production, cystine and oxidized glutathione had an
effect similar to that of cysteine or reduced glutathione, and in
certain conditions, pigment production does not require anaerobiosis
(12). These facts could indicate that the effect of
sulphur-containing compounds is not a consequence solely of the
reduction of the redox potential of the medium. In addition, the
chemical nature of GBS pigment, the biochemical pathway that leads to
its synthesis, and its physiological role are not known
(19). Because of all that, it is difficult to hypothesize
about the role of sulphur-containing compounds and reducing agents in
GBS pigment production. There is approximately 800 µg of cystine/ml
(in peptides from the albumin digest) in all the media studied, and
though this fulfills the nutritional requirements (GBS grow in AM and
CAM media without cysteine), there is no effect on pigment production.
Perhaps this means that in addition to the active peptide
Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe, the presence of sulfur-containing
compounds as free small molecules is necessary for GBS pigment
production, and when they are not present pigment production requires
reducing agents. How these compounds cause this effect is not clear,
and further work is necessary to investigate this.
The use of media for identification of GBS based on pigment is a
promising approach to its detection in clinical samples
(3), e.g., Granada medium, which is now marketed in the
United States (Hardy Diagnostics, Santa Maria, Calif.) and in the
European Union (Biomedics, Madrid, Spain). These media are empirically
designed, and knowledge of the role that sulphur-containing compounds
play in production of pigment and availability of defined media for GBS
pigment production could help to improve them.
 |
ACKNOWLEDGMENTS |
This work was supported by a grant from the FIS, Spanish Ministry
of Health (Project 00/0897) and by a grant from the Consejeria de Salud
of Andalusia Autonomous Government.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Servicio de
Microbiologia, Hospital Virgen de las Nieves, 18014 Granada, Spain.
Phone: 34-958-241109. Fax: 34-958-241282. E-mail:
delarosa{at}cica.es.
 |
REFERENCES |
| 1.
|
Eagle, H.
1959.
Amino acid metabolism in mammalian cell culture.
Science
130:432-437[Free Full Text].
|
| 2.
|
Islam, A. K. M.
1977.
Rapid recognition of group B streptococci.
Lancet
i:256-257.
|
| 3.
|
Koneman, E. W.,
D. D. Allen,
W. M. Janda,
P. C. Schreckenberger, and W. C. Winn.
1997.
Gram positive cocci, p. 608.
In
Color atlas and textbook of diagnostic microbiology, 5th ed. Lippincott, Philadelphia, Pa.
|
| 4.
|
Merritt, K., and J. N. Jacobs.
1976.
Improved medium for detecting pigment production by group B streptococci.
J. Clin. Microbiol.
4:379-380[Abstract/Free Full Text].
|
| 5.
|
Merritt, K., and J. N. Jacobs.
1978.
Characterization and incidence of pigment production by human clinical group B streptococci.
J. Clin. Microbiol.
8:105-107[Abstract/Free Full Text].
|
| 6.
|
Mickelson, M. N.
1976.
Effects of nutritional characteristics of Streptococcus agalactiae on inhibition of growth by lactoperoxidase-thiocyanate-hydrogen peroxide in chemically defined medium.
Appl. Environ. Microbiol.
32:238-244[Abstract/Free Full Text].
|
| 7.
|
Milligan, T. W.,
T. I. Doran,
D. C. Straus, and S. J. Mattingly.
1978.
Growth and amino acid requirements of various strains of group B streptococci.
J. Clin. Microbiol.
7:28-33[Abstract/Free Full Text].
|
| 8.
|
Rosa, M.,
D. Villarreal,
D. Vega,
C. Miranda, and A. Martinez-Brocal.
1983.
Granada medium for detection and identification of group B streptococci.
J. Clin. Microbiol.
18:779-785[Abstract/Free Full Text].
|
| 9.
|
Rosa, M.,
M. Perez,
C. Carazo,
L. Pareja,
J. I. Peis, and F. Hernández.
1992.
New Granada medium for detection and identification of group B streptococci.
J. Clin. Microbiol.
30:1019-1021[Abstract/Free Full Text].
|
| 10.
|
Rosa-Fraile, M.,
A. Sampedro,
A. Ruiz-Bravo,
S. Sanbonmatsu, and G. Gimenez-Gallego.
1996.
Identification of serum and urine proteins responsible for enhanced pigment production by group B streptococci as amylases.
Clin. Diagn. Lab. Immunol.
3:594-596[Abstract].
|
| 11.
|
Rosa-Fraile, M.,
A. Sampedro,
J. Varela,
M. García-Peña, and G. Gimenez-Gallego.
1999.
Identification of a peptide from mammal albumins responsible for enhanced pigment production by group B streptococci.
Clin. Diagn. Lab. Immunol.
6:425-426[Abstract/Free Full Text].
|
| 12.
|
Rosa-Fraile, M.,
J. Rodriguez-Granger,
M. Cueto-López,
A. Sampedro,
E. Biel Gaye,
J. M. Haro, and A. Andreu.
1999.
Use of Granada medium to detect group B streptococcal colonization in pregnant women.
J. Clin. Microbiol.
37:2674-2677[Abstract/Free Full Text].
|
| 13.
|
Ruoff, K. L.,
R. A. Whiley, and D. Beighton.
1999.
Streptococcus, p. 283-296.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D. C.
|
| 14.
|
Schrag, S. J.,
S. Zywicki,
M. M. Farley,
A. L. Reingold,
L. E. Harrison,
L. B. Lefkowitz,
J. L. Hadler,
M. Danila,
P. R. Cieslak, and A. Schuchat.
2000.
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
N. Engl. J. Med.
342:15-20[Abstract/Free Full Text].
|
| 15.
|
Spellerberg, B.,
B. Pohl,
G. Haase,
S. Martin,
J. Weber-Heynemann, and R. Lutticken.
1999.
Identification of genetic determinants for the haemolytic activity of Streptococcus agalactiae by ISS1 transposition.
J. Bacteriol.
181:3212-3219[Abstract/Free Full Text].
|
| 16.
|
Tapsall, J. W.
1986.
Pigment production by Lancefield-group B streptococci (Streptococcus agalactiae).
J. Med. Microbiol.
21:75-81[Abstract].
|
| 17.
|
Tapsall, J. W.
1987.
Relationship between pigment production and haemolysin formation by Lancefield group B streptococci.
J. Med. Microbiol.
24:83-87[Abstract].
|
| 18.
|
Terleckyj, B.,
N. P. Willet, and G. D. Shockman.
1975.
Growth of several cariogenic strains of oral streptococci in a chemically defined medium.
Infect. Inmun.
11:649-655[Abstract/Free Full Text].
|
| 19.
|
Wennestrom, D. E.,
L. N. Lee,
A. G. Baseman,
D. J. LeBlanc,
C. E. Cerniglia, and K. M. Trotter.
1991.
Genetics and characterization of group B streptococcal pigment, p. 224.
In
G. M. Dunny, P. P. Cleary, and L. L. McKay (ed.), Genetics and molecular biology of Streptococcus, Lactococcus, and Enterococci. American Society for Microbiology, Washington, D.C.
|
| 20.
|
Willet, N. P., and G. E. Morse.
1966.
Long chain fatty acid inhibition of growth of Streptococcus agalactiae in a chemically defined medium.
J. Bacteriol.
91:2245-2250[Abstract/Free Full Text].
|
Applied and Environmental Microbiology, January 2001, p. 473-474, Vol. 67, No. 1
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.1.473-474.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.